SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 133 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1 | -96.7% | 791 | -98.0% | 0.00% | – |
Q1 2024 | $30 | -44.4% | 39,336 | +1.4% | 0.00% | – |
Q4 2023 | $54 | -41.9% | 38,807 | -0.8% | 0.00% | – |
Q3 2023 | $93 | -49.7% | 39,105 | +1.3% | 0.00% | – |
Q2 2023 | $185 | 0.0% | 38,590 | +18.5% | 0.00% | – |
Q1 2023 | $185 | -32.7% | 32,570 | -33.6% | 0.00% | – |
Q4 2022 | $275 | -99.9% | 49,070 | -0.1% | 0.00% | – |
Q3 2022 | $315,000 | +87.5% | 49,106 | +0.2% | 0.00% | – |
Q2 2022 | $168,000 | -51.9% | 48,993 | -0.2% | 0.00% | – |
Q1 2022 | $349,000 | -15.9% | 49,076 | -1.6% | 0.00% | – |
Q4 2021 | $415,000 | +55.4% | 49,856 | +29.8% | 0.00% | – |
Q3 2021 | $267,000 | -81.4% | 38,407 | -36.0% | 0.00% | -100.0% |
Q2 2021 | $1,432,000 | +35.6% | 60,047 | +17.1% | 0.00% | 0.0% |
Q1 2021 | $1,056,000 | -17.6% | 51,300 | -1.9% | 0.00% | 0.0% |
Q4 2020 | $1,281,000 | +6.9% | 52,300 | +23.6% | 0.00% | 0.0% |
Q3 2020 | $1,198,000 | +524.0% | 42,300 | +5.0% | 0.00% | – |
Q2 2020 | $192,000 | +178.3% | 40,300 | +108.8% | 0.00% | – |
Q1 2020 | $69,000 | +3.0% | 19,300 | 0.0% | 0.00% | – |
Q4 2019 | $67,000 | -13.0% | 19,300 | 0.0% | 0.00% | – |
Q3 2019 | $77,000 | +24.2% | 19,300 | 0.0% | 0.00% | – |
Q2 2019 | $62,000 | -53.4% | 19,300 | 0.0% | 0.00% | – |
Q1 2019 | $133,000 | +52.9% | 19,300 | 0.0% | 0.00% | – |
Q4 2018 | $87,000 | -40.4% | 19,300 | 0.0% | 0.00% | – |
Q3 2018 | $146,000 | -12.0% | 19,300 | 0.0% | 0.00% | – |
Q2 2018 | $166,000 | +16.9% | 19,300 | 0.0% | 0.00% | – |
Q1 2018 | $142,000 | -39.8% | 19,300 | -17.2% | 0.00% | – |
Q4 2017 | $236,000 | -36.9% | 23,300 | 0.0% | 0.00% | – |
Q3 2017 | $374,000 | +42.2% | 23,300 | 0.0% | 0.00% | – |
Q2 2017 | $263,000 | +59.4% | 23,300 | +59.6% | 0.00% | – |
Q1 2017 | $165,000 | +13.8% | 14,601 | +0.0% | 0.00% | – |
Q4 2016 | $145,000 | -19.0% | 14,600 | 0.0% | 0.00% | – |
Q3 2016 | $179,000 | -30.9% | 14,600 | +64.0% | 0.00% | – |
Q2 2016 | $259,000 | +9.7% | 8,900 | 0.0% | 0.00% | – |
Q1 2016 | $236,000 | -1.3% | 8,900 | +30.9% | 0.00% | – |
Q4 2015 | $239,000 | – | 6,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
Knott David M Jr | 110,000 | $706,000 | 0.30% |
Atom Investors LP | 108,820 | $699,000 | 0.25% |
Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |